drugset / Trial / NCT00707551

An Interaction Study of Ketoconazole/Verapamil Versus AZD1305

NCT00707551

Phase 1 Completed 27 enrolled AstraZeneca
RandomizedCrossoverOpen-labelTreatment

Summary

The purpose is to study whether ketoconazole or verapamil have an effect on how AZD1305 is handled by the body, i.e the absorption, distribution, metabolism and excretion, when administered in combination with AZD1305.

Timeline

Start
2008-07
Primary completion
2008-11
Completion
2008-11

Drugs

EvaluationDrugModalityDoseRoute
Subject AZD1305 Small molecule
Subject Ketoconazole Small molecule
Subject Verapamil Other / unclassified

Indications

No indication recorded.